Czech-based Mewery has introduced a prototype of microalgae-based cultivated meat, combining 75 percent pork cells and 25 percent microalgae cells.
The scientific team of Mewery, a cell-based food tech start-up, , cultivated this prototype in 10 weeks.
According to Mewery founder, Roman Lauš, they already have several variants that work for them without animal products and which they continue to work with.
The addition of microalgae improves the product's nutritional value by providing vitamins, antioxidants, minerals, fiber, and vital fatty acids.
Mewery hopes to have the finished product available for sale in two years. Once the necessary legislation is ready, consumers will have access to it.


Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
Australia’s December Trade Surplus Expands but Falls Short of Expectations
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Asian Markets Slip as AI Spending Fears Shake Tech, Wall Street Futures Rebound
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Oil Prices Slip as U.S.–Iran Talks Ease Supply Disruption Fears
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 



